Food for thought … on evidence-based toxicology
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
I would like to devote the first article of this series that I am writing after my move to the US to the topic that has become my chair’s designation, i.e. evidence-based toxicology. this topic is really close to my heart. It all began in 1993, when my friend edmund “edi” Neugebauer co-edited the book “Handbook of Mediators in Septic Shock” (Neugebauer and Holaday, 1993). To the best of my knowledge, this was the first book to apply principles of evidence-based medicine (eBM) not only to clinical studies but also to animal studies and in vitro experimental work. So, when I started at eCVAM in 2002 and was developing ideas for possible directions to take, my list included evidence-based toxicology, i.e. the translation of eBM (for an introduction to this see, for example, Mayer, 2004) to toxicology, as a most interesting option. I was most fortunate that a Ph.D. student of mine at that time, Sebastian Hoffmann, who is a statistician by training, not only joined me to go from Konstanz to eCVAM, but agreed to refocus his thesis under my supervision to developing the concepts of an evidence-based toxicology (eBt). His thesis “evidence-based in vitro toxicology,” submitted in January 2005 to the University of Konstanz (Hoffmann, 2005), is the first extensive publication on EBT, as far as I am aware. Sure, there were a few previous attempts to link eBM and toxicology (Buckley and Smith, 1996), especially in the discussion around the toxicity of amalgam (Dodes, 2001). Also, Phil Guzelian and co-authors (Guzelian et al., 2005) independently developed a concept for eBt, though they took a different approach, focusing on causation and not on method evaluation (see below). One might ask whether these “Food for thought” articles are not the opposite of evidence-based. they are by purpose personal, provocative, not really peer-reviewed, not evaluated by statistics, broad in scope, etc. that is correct, but they also do not pretend to produce new knowledge but try to challenge common beliefs and stimulate new thinking. By this, they might, however, occasionally initiate a systematic review in the spirit of eBM and eBt. With this disclaimer in mind, let’s get into evidence-based science. Consideration 1: EBM tries to solve some problems that are strikingly similar to those of toxicology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Qualitative Research: Consensus methods for medical and health services research
Jones, J., & Hunter, D. (1995) · BMJ · doi:10.1136/bmj.311.7001.376 · Cited by 3,471 · cited 2×
“there is a wealth of literature on these methodologies, such as the Delphi process and the nominal group technique (Fink et al., 1984; Williams and Webb, 1994; Jones and Hunter, 1995).”
Consensus methods: characteristics and guidelines for use
Fink, A., Kosecoff, J., Chassin, M., & Brook, R. H. (1984) · American Journal of Public Health · doi:10.2105/ajph.74.9.979 · Cited by 2,089 · cited 2×
“there is a wealth of literature on these methodologies, such as the Delphi process and the nominal group technique (Fink et al., 1984; Williams and Webb, 1994; Jones and Hunter, 1995).”
Systematic Reviews: Rationale for systematic reviews
Mulrow, C. D. (1994) · BMJ · doi:10.1136/bmj.309.6954.597 · Cited by 1,677
A Modular Approach to the ECVAM Principles on Test Validity
Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A. J., et al. (2004) · Alternatives to Laboratory Animals · doi:10.1177/026119290403200503 · Cited by 341 · cited 2×
“One opportunity identified and then formalised in the modular approach to test validation (Hartung et al., 2004) was the introduction of retrospective validation.”
Navas-Acien, A., Silbergeld, E. K., Streeter, R. A., Clark, J. M., Burke, T. A., & Guallar, E. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8551 · Cited by 339 · cited 2×
“Meta-analysis as used in the clinical field is most promising here. ellen Silbergeld’s structured reviews are forerunners for this approach (Navas-Acien et al., 2006; 2007).”
Development of The Cochrane Collaboration's Central Register of Controlled Clinical Trials
Dickersin, K., Manheimer, E., Wieland, S., Robinson, K. A., Lefebvre, C., & McDonald, S. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702025001004 · Cited by 198
Cited by
Adverse outcome pathways: opportunities, limitations and open questions
Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2045-3 · Cited by 394
Toxicity testing in the 21st century: progress in the past decade and future perspectives
Krewski, D., Andersen, M. E., Tyshenko, M. G., Krishnan, K., Hartung, T., Boekelheide, K., Wambaugh, J. F., Jones, D., Whelan, M., Thomas, R., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02613-4 · Cited by 383
Self-citationValidation and quality control of replacement alternatives - current status and future challenges
Leist, M., Hasiwa, N., Daneshian, M., & Hartung, T. (2012) · Toxicology Research · doi:10.1039/c2tx20011b · Cited by 100
Food for Thought … Mechanistic Validation
Hartung, T. (2013) · ALTEX · doi:10.14573/altex.2013.2.119 · Cited by 93
“We have stressed (Hartung, 2009) that the call for evidence-based toxicology (EBT) has two roots – Philip Guzelian's group's proposal for a more rigorous approach to causation of chemical effects (Guzelian et al.”
InfluentialAlternative in vitro assays in nanomaterial toxicology
Hartung, T., & Sabbioni, E. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.153 · Cited by 84
Metadata
- Authors
- Hartung, T.
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2009
- Volume
- 26
- Issue
- 2
- Pages
- 75-82
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2413055582
- Cited by
- 56
- References
- 6
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.